William J.  Febbo net worth and biography

William Febbo Biography and Net Worth

CEO of OptimizeRx
Over the last 20 years, Will has led health service, technology and finance companies, connecting key participants in the healthcare industry. As CEO and Director of OptimizeRx, he has continued to drive innovation in healthcare, and over the last several years, he has led the transformation of OptimizeRx into a leading digital health company that facilitates communication at the point-of-care for better health outcomes.

In 1999, Will co-founded and became CEO of MedPanel, a market intelligence and communication provider to the life sciences and financial industries. MedPanel was acquired in 2007 by Merriman Capital, a leading investment bank. At Merriman, he served as COO of investment banking and CEO of the firm’s Digital Capital Network. He launched pioneering digital compliance and transparency products and was part of the management team that raised more than $500 million in banking and M&A transactions.

Will earlier held a number of M&A and international business development roles at multinational companies involved in automotive, medical, precious metals and other industries.  

He currently serves as a faculty member for Massachusetts Institute of Technology’s linQ program, a collaborative initiative increasing the potential of innovative biomedical research to benefit society and the economy.

Will serves on board of The United Nations of Greater Boston, a non-profit focused on building a stronger network of global citizens in the Boston area. He also serves as a board member of Modular Medical, an early stage public medical device company. 

Will earned his Bachelor of Arts in International Studies and Spanish from Dickinson College, Pennsylvania. He is fluent in Spanish, married with three children and enjoys playing soccer.

What is William J. Febbo's net worth?

The estimated net worth of William J. Febbo is at least $1.99 million as of August 19th, 2022. Mr. Febbo owns 451,072 shares of OptimizeRx stock worth more than $1,993,738 as of November 21st. This net worth evaluation does not reflect any other assets that Mr. Febbo may own. Additionally, Mr. Febbo receives an annual salary of $863,150.00 as CEO at OptimizeRx. Learn More about William J. Febbo's net worth.

How old is William J. Febbo?

Mr. Febbo is currently 55 years old. There are 2 older executives and no younger executives at OptimizeRx. Learn More on William J. Febbo's age.

What is William J. Febbo's salary?

As the CEO of OptimizeRx Co., Mr. Febbo earns $863,150.00 per year. Learn More on William J. Febbo's salary.

How do I contact William J. Febbo?

The corporate mailing address for Mr. Febbo and other OptimizeRx executives is 400 WATER STREET SUITE 200, ROCHESTER MI, 48307. OptimizeRx can also be reached via phone at (248) 651-6568 and via email at [email protected]. Learn More on William J. Febbo's contact information.

Has William J. Febbo been buying or selling shares of OptimizeRx?

William J. Febbo has not been actively trading shares of OptimizeRx in the last ninety days. Most recently, on Monday, August 22nd, William J. Febbo bought 10,700 shares of OptimizeRx stock. The stock was acquired at an average cost of $15.29 per share, with a total value of $163,603.00. Following the completion of the transaction, the chief executive officer now directly owns 461,772 shares of the company's stock, valued at $7,060,493.88. Learn More on William J. Febbo's trading history.

Who are OptimizeRx's active insiders?

OptimizeRx's insider roster includes Douglas Baker (CFO), William Febbo (CEO), Miriam Paramore (Insider), Stephen Silvestro (Insider), and Patrick Spangler (Director). Learn More on OptimizeRx's active insiders.

Are insiders buying or selling shares of OptimizeRx?

During the last twelve months, insiders at the sold shares 1 times. They sold a total of 4,000 shares worth more than $60,760.00. The most recent insider tranaction occured on January, 9th when General Counsel Marion Odence-Ford sold 4,000 shares worth more than $60,760.00. Insiders at OptimizeRx own 6.1% of the company. Learn More about insider trades at OptimizeRx.

Information on this page was last updated on 1/9/2024.

William J. Febbo Insider Trading History at OptimizeRx

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/22/2022Buy10,700$15.29$163,603.00461,772View SEC Filing Icon  
8/19/2022Buy5,400$16.18$87,372.00451,072View SEC Filing Icon  
2/18/2022Sell16,666$43.73$728,804.18View SEC Filing Icon  
1/18/2022Sell16,666$47.27$787,801.82View SEC Filing Icon  
12/15/2021Sell16,666$54.55$909,130.30View SEC Filing Icon  
11/15/2021Sell16,666$82.18$1,369,611.88View SEC Filing Icon  
10/15/2021Sell16,666$84.20$1,403,277.20View SEC Filing Icon  
3/25/2021Sell80,000$46.10$3,688,000.00273,278View SEC Filing Icon  
11/6/2019Buy5,000$10.38$51,900.00
12/19/2018Buy2,000$9.94$19,880.00View SEC Filing Icon  
11/7/2018Buy600$16.32$9,792.00View SEC Filing Icon  
6/22/2018Buy1,000$10.50$10,500.00View SEC Filing Icon  
12/1/2016Buy4,000$0.85$3,400.0044,000View SEC Filing Icon  
11/10/2016Buy9,000$0.90$8,100.0040,000View SEC Filing Icon  
6/9/2016Buy21,567$1.08$23,292.3619,433View SEC Filing Icon  
See Full Table

William J. Febbo Buying and Selling Activity at OptimizeRx

This chart shows William J Febbo's buying and selling at OptimizeRx by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

OptimizeRx Company Overview

OptimizeRx logo
OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.
Read More

Today's Range

Now: $4.35
Low: $4.32
High: $4.49

50 Day Range

MA: $6.41
Low: $3.83
High: $8.16

2 Week Range

Now: $4.35
Low: $3.78
High: $16.65

Volume

136,613 shs

Average Volume

146,366 shs

Market Capitalization

$80.13 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.32